fda announcement semaglutide US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Wegovy® Lawsuit | July 2026

This blog explores the characterization of GLP-1 peptide impurities, highlighting key strategies and methodologies

Age-associated declines in renal and hepatic function, coupled with changes in body compositionsuch as increased fat-to-lean mass ratiocan modify drug distribution and clearance

Yes, GLP-1 PAs can be time-consuming

A seven-day thymosin beta-4 animal study also does not mean KLOW should be studied for seven days

26 Subject to CMS approval, however, states may implement certain state directed payments (SDPs) 27 that require MCOs to adopt minimum or maximum provider payment fee schedules, provide uniform dollar or percentage increases to network providers (above base payment rates), or implement value-based provider payment arrangements